Two Sigma Investments’s NovoCure NVCR Stock Holding History

Two Sigma Investments’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-11,600	Closed	-$1.35M	–	4685
2021 Q3	$1.35M	Buy	+11,600	New	+$1.75M	﹤0.01%	2339
2021 Q2	–	Sell	-14,300	Closed	-$1.89M	–	4419
2021 Q1	$1.89M	Buy	14,300 +10,500	+276%	+$1.66M	﹤0.01%	1757
2020 Q4	$658K	Buy	+3,800	New	+$520K	﹤0.01%	2307
2020 Q3	–	Sell	-13,000	Closed	-$771K	–	3412
2020 Q2	$771K	Sell	13,000 -5,400	-29%	-$355K	﹤0.01%	1706
2020 Q1	$1.24M	Buy	18,400 +14,800	+411%	+$1.17M	0.01%	1262
2019 Q4	$303K	Sell	3,600 -27,300	-88%	-$2.2M	﹤0.01%	3180
2019 Q3	$2.31M	Buy	30,900 +26,900	+673%	+$2.15M	0.01%	1317
2019 Q2	$253K	Buy	+4,000	New	+$203K	﹤0.01%	2955

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Two Sigma Investments's NVCR Position: Q1 2026 in Review

Two Sigma Investments reduced its NovoCure (NVCR) stake by 87% in Q1 2026, selling an estimated $3.84M and leaving 45,318 shares worth $494K. The position accounts for ﹤0.01% of the portfolio, ranked #3755.

Two Sigma Investments first reported a position in NVCR in Q4 2015 and has held it in 34 quarters since. The position peaked at $50M in Q1 2021. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

Two Sigma Investments held 45,318 shares of NovoCure worth $494K as of Q1 2026.
Two Sigma Investments sold 307,141 NovoCure shares in Q1 2026, an estimated $3.84M.
NovoCure made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #3755 holding.
Two Sigma Investments first reported a position in NovoCure in Q4 2015 and has held it in 34 quarters since.
Two Sigma Investments's NovoCure position peaked at $50M in Q1 2021.
222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.